Achieve Life Sciences
ACHV
15 hedge funds and large institutions have $797K invested in Achieve Life Sciences in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 12 closing their positions.
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
40% less funds holding
Funds holding: 25 → 15 (-10)
45% less capital invested
Capital invested by funds: $1.46M → $797K (-$659K)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$163K |
| 2 |
VF
Virtu Financial
New York
|
+$59.6K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$51.7K |
| 4 |
Renaissance Technologies
New York
|
+$24.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$19.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$71.1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$25K |
| 4 |
Bank of New York Mellon
New York
|
-$22K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$18K |
ACHV Hedge Fund Activity: Q3 2017 in Review
15 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2017, worth a combined $797K — down 45% from $1.46M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ACHV and 3 opened new positions — a net loss of 9 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $163K. The largest seller was Panagora Asset Management, cutting an estimated $71.1K.
- 15 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2017, down from 25 in Q2 2017.
- Funds reported $797K of Achieve Life Sciences stock for Q3 2017, down 45% quarter-over-quarter.
- 3 funds opened new Achieve Life Sciences positions in Q3 2017 and 12 closed out, a net change of -9 holders.
- The largest Achieve Life Sciences buyer in Q3 2017 was Vanguard Group, an estimated $163K added.
- The largest Achieve Life Sciences seller in Q3 2017 was Panagora Asset Management, an estimated $71.1K sold.
Based on aggregated 13F filings for Q3 2017.